Background And Aims: Cannabis use is common among people on opioid agonist treatment (OAT), causing concern for some care providers. However, there is limited and conflicting evidence on the impact of cannabis use on OAT outcomes. Given the critical role of retention in OAT in reducing opioid-related morbidity and mortality, we aimed to estimate the association of at least daily cannabis use on the likelihood of retention in treatment among people initiating OAT. As a secondary aim we tested the impacts of less frequent cannabis use.
Design: Data were drawn from two community-recruited prospective cohorts of people who use illicit drugs (PWUD). Participants were followed for a median of 81 months (interquartile range = 37-130).
Setting: Vancouver, Canada.
Participants: This study comprised a total of 820 PWUD (57.8% men, 59.4% of Caucasian ethnicity, 32.2% HIV-positive) initiating OAT between December 1996 and May 2016. The proportion of women was higher among HIV-negative participants, with no other significant differences.
Measurements: The primary outcome was retention in OAT, defined as remaining in OAT (methadone or buprenorphine/naloxone-based) for two consecutive 6-month follow-up periods. The primary explanatory variable was cannabis use (at least daily versus less than daily) during the same 6-month period. Confounders assessed included: socio-demographic characteristics, substance use patterns and social-structural exposures.
Findings: In adjusted analysis, at least daily cannabis use was positively associated with retention in OAT [adjusted odds ratio (aOR) = 1.21, 95% confidence interval (CI) = 1.04-1.41]. Our secondary analysis showed that compared with non-cannabis users, at least daily users had increased odds of retention in OAT (aOR = 1.20, 95% CI = 1.02-1.43), but not less than daily users (aOR = 1.00, 95% CI = 0.87-1.14).
Conclusions: Among people who use illicit drugs initiating opioid agonist treatment in Vancouver, at least daily cannabis use was associated with approximately 21% greater odds of retention in treatment compared with less than daily consumption.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226334 | PMC |
| http://dx.doi.org/10.1111/add.14398 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pharmacological Strategies to Decrease Long-Term Prescription Opioid Use: A Systematic Review.
J Clin Med
December 2024
Department of Pharmacy, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
: As long-term prescription opioid use is associated with increased morbidity and mortality, timely dose reduction of prescription opioids should be considered. However, most research has been conducted on patients using heroin. Given the differences between prescription and illicit opioid use, the aim of this review was to provide an overview of pharmacological strategies to reduce prescription opioid use or improve clinical outcomes for people who experience long-term prescription opioid use, including those with opioid use disorder.
View Article and Find Full Text PDFBenzodiazepine agonist treatment for patients with benzodiazepine dependence undergoing opioid agonist treatment: a study protocol for the randomized controlled trial BMX-BAR.
Trials
January 2025
Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.
Background: There is a lack of knowledge on effective treatment methods for comorbid benzodiazepine dependence in populations undergoing opioid agonist treatment (OAT). Tapering and discontinuation of benzodiazepines has long been considered the standard treatment, even though there is limited evidence for this practice. There is also limited research on benzodiazepine agonist treatment; however, peer and clinical experiences indicate that such approaches may be beneficial for a subgroup of the patients with long-lasting benzodiazepine dependence not responding to other treatment approaches.
View Article and Find Full Text PDFThe Impact of Longitudinal Substance Use Patterns on the Risk of Opioid Agonist Therapy Discontinuation: A Repeated Measures Latent Class Analysis.
Int J Ment Health Addict
June 2023
British Columbia Centre on Substance Use, 400-1045 Howe Street, Vancouver, BC Canada.
Unlabelled: Polysubstance use is prevalent among individuals on opioid agonist treatment (OAT), yet past studies have focused primarily on distinct substances and their association with OAT retention. Data was collected from two prospective cohorts between 2005 and 2020 in Vancouver, Canada. Among 13,596 visits contributed by 1445 participants receiving OAT, we employed repeated measures latent class analysis using seven indicators and identified four longitudinal substance use classes.
View Article and Find Full Text PDFTransformation of the HIV treatment cascade for people who inject drugs in Ukraine.
AIDS
November 2024
Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine.
Article Synopsis
- Ukraine experiences a significant HIV epidemic predominantly among people who inject drugs, especially opioids, but has notably increased the use of opioid agonist therapies (OAT) between 2014 and 2021.
- A biobehavioral survey conducted on opioid-dependent people who inject drugs (PWID) in 2020-2021 revealed improvements in HIV diagnosis, care, and treatment compared to a prior survey from 2014-2015.
- The study highlights that any interaction with the OAT system—regardless of ongoing treatment—enhances HIV care engagement and treatment outcomes, demonstrating the positive impact of this approach on the overall HIV care cascade.
Influence of particle size and inclusion level of oat hulls on retention and passage in the anterior digestive tract of broilers.
Br Poult Sci
November 2024
Department of Animal and Aquacultural Sciences, Norwegian University of Life Sciences (NMBU), Ås, Norway.
Article Synopsis
- The study examined how different ratios of whole and dehulled oats, ground to different sizes, affect gizzard function and the passage of large oat hull particles in broilers.* -
- Results showed that gizzard contents had significantly higher neutral detergent fiber, indicating that it selectively retains larger oat hull particles until a certain limit, after which larger particles pass through unground.* -
- An experiment revealed that larger oat hull particles were less broken down and passed more readily into excreta over time, challenging the assumption that all particles are ground to a critical size before moving through the digestive system.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!